tiprankstipranks
Athens Medical Center SA (DE:ACS)
FRANKFURT:ACS
Germany Market

Athens Medical Center (ACS) Ratios

1 Followers

Athens Medical Center Ratios

DE:ACS's free cash flow for Q4 2025 was €0.21. For the 2025 fiscal year, DE:ACS's free cash flow was decreased by € and operating cash flow was €>-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
0.76 0.76 0.83 0.98 1.10
Quick Ratio
0.74 0.74 0.80 0.95 1.05
Cash Ratio
0.11 0.11 0.08 0.11 0.11
Solvency Ratio
0.03 0.03 0.05 0.06 0.07
Operating Cash Flow Ratio
0.02 0.02 0.20 0.13 <0.01
Short-Term Operating Cash Flow Coverage
0.05 0.05 0.82 0.52 <0.01
Net Current Asset Value
€ -209.12M€ -209.12M€ -195.18M€ -171.58M€ -155.01M
Leverage Ratios
Debt-to-Assets Ratio
0.34 0.34 0.30 0.33 0.34
Debt-to-Equity Ratio
1.76 1.76 1.36 1.46 1.40
Debt-to-Capital Ratio
0.64 0.64 0.58 0.59 0.58
Long-Term Debt-to-Capital Ratio
0.37 0.37 0.39 0.45 0.52
Financial Leverage Ratio
5.13 5.13 4.57 4.39 4.05
Debt Service Coverage Ratio
0.24 0.24 0.44 0.54 1.11
Interest Coverage Ratio
0.34 0.34 1.43 2.44 2.37
Debt to Market Cap
1.19 0.93 0.97 0.87 1.04
Interest Debt Per Share
2.23 2.23 1.82 1.94 1.75
Net Debt to EBITDA
5.44 5.44 4.06 3.61 3.95
Profitability Margins
Gross Profit Margin
20.36%20.36%22.52%25.76%24.34%
EBIT Margin
3.02%3.02%5.63%8.85%7.88%
EBITDA Margin
10.08%10.08%11.86%14.63%13.82%
Operating Profit Margin
1.41%1.41%5.65%8.94%7.89%
Pretax Profit Margin
-1.09%-1.09%1.67%5.30%4.59%
Net Profit Margin
-1.69%-1.69%0.66%3.13%2.93%
Continuous Operations Profit Margin
-1.67%-1.67%0.70%3.16%2.96%
Net Income Per EBT
155.25%155.25%39.59%58.99%63.90%
EBT Per EBIT
-77.27%-77.27%29.46%59.31%58.21%
Return on Assets (ROA)
-0.88%-0.88%0.36%1.69%1.64%
Return on Equity (ROE)
-4.37%-4.49%1.64%7.44%6.63%
Return on Capital Employed (ROCE)
1.59%1.59%5.75%8.34%6.75%
Return on Invested Capital (ROIC)
1.11%1.11%1.95%4.12%4.02%
Return on Tangible Assets
-0.89%-0.89%0.36%1.70%1.64%
Earnings Yield
-3.47%-2.72%1.36%4.98%5.56%
Efficiency Ratios
Receivables Turnover
1.59 1.59 1.69 1.64 1.83
Payables Turnover
1.82 1.82 2.01 2.12 2.20
Inventory Turnover
28.04 28.04 29.01 27.63 25.22
Fixed Asset Turnover
0.92 0.92 0.92 0.95 0.92
Asset Turnover
0.52 0.52 0.54 0.54 0.56
Working Capital Turnover Ratio
-4.68 -5.16 -12.79 46.92 11.00
Cash Conversion Cycle
42.10 42.10 46.16 63.80 48.62
Days of Sales Outstanding
229.41 229.41 215.43 223.09 199.77
Days of Inventory Outstanding
13.02 13.02 12.58 13.21 14.48
Days of Payables Outstanding
200.33 200.33 181.85 172.50 165.63
Operating Cycle
242.43 242.43 228.01 236.30 214.25
Cash Flow Ratios
Operating Cash Flow Per Share
0.06 0.06 0.54 0.30 <0.01
Free Cash Flow Per Share
-0.14 -0.14 0.23 0.04 -0.18
CapEx Per Share
0.20 0.20 0.31 0.26 0.18
Free Cash Flow to Operating Cash Flow
-2.25 -2.33 0.43 0.15 -127.02
Dividend Paid and CapEx Coverage Ratio
0.31 0.30 1.64 1.17 <0.01
Capital Expenditure Coverage Ratio
0.31 0.30 1.74 1.17 <0.01
Operating Cash Flow Coverage Ratio
0.03 0.03 0.32 0.17 <0.01
Operating Cash Flow to Sales Ratio
0.02 0.02 0.17 0.10 <0.01
Free Cash Flow Yield
-8.71%-6.89%15.13%2.35%-12.79%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-28.81 -36.80 73.66 20.07 17.99
Price-to-Sales (P/S) Ratio
0.49 0.62 0.49 0.63 0.53
Price-to-Book (P/B) Ratio
1.29 1.65 1.21 1.49 1.19
Price-to-Free Cash Flow (P/FCF) Ratio
-11.48 -14.52 6.61 42.57 -7.82
Price-to-Operating Cash Flow Ratio
25.82 33.75 2.82 6.20 993.27
Price-to-Earnings Growth (PEG) Ratio
0.08 0.10 -0.94 1.11 -0.38
Price-to-Fair Value
1.29 1.65 1.21 1.49 1.19
Enterprise Value Multiple
10.27 11.62 8.15 7.90 7.77
Enterprise Value
285.55M 322.85M 260.77M 298.74M 250.54M
EV to EBITDA
10.27 11.62 8.15 7.90 7.77
EV to Sales
1.04 1.17 0.97 1.16 1.07
EV to Free Cash Flow
-24.38 -27.29 13.16 78.41 -15.91
EV to Operating Cash Flow
54.84 63.45 5.61 11.42 2.02K
Tangible Book Value Per Share
1.11 1.11 1.18 1.22 1.18
Shareholders’ Equity Per Share
1.20 1.20 1.25 1.25 1.19
Tax and Other Ratios
Effective Tax Rate
-0.54 -0.54 0.58 0.40 0.35
Revenue Per Share
3.18 3.18 3.11 2.98 2.69
Net Income Per Share
-0.05 -0.05 0.02 0.09 0.08
Tax Burden
1.55 1.55 0.40 0.59 0.64
Interest Burden
-0.36 -0.36 0.30 0.60 0.58
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.17 0.03 0.03 0.02 0.02
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
-1.73 -1.69 10.33 3.24 0.01
Currency in EUR